SEC Form 4 · accession 0002063082-26-000003
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy Parison
Officer — SVP, Chief Financial Officer
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:07 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2026 | S | 678 | $2.58 | D | 14,292 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 1, 2026. The sale does not represent a discretionary trade by the Reporting Person.